Ogeda's Acquisition

Ogeda was acquired by Astellas Pharma on April 03, 2017.

Ogeda, fka Euroscreen, is a clinical-stage drug discovery company that discovers and develops small molecule drugs targeting G-protein coupled receptors (GPCRs).…

Articles about Ogeda's Acquisition: